2-(4-BROMOPHENYL)-4,5-DIHYDRO-4,4-DIMETHYLOXAZOLE, 95.0%, 10g

4-Bromo-3-fluorophenylacetonitrile, 95.0%, 1g

2'-Chloro-biphenyl-3-carbaldehyde, 95+%, 250mg

5-Norbornene-2,3-dimethanol, 95.0%, 5g

FMOC-2-FLUORO-D-PHENYLALANINE, 95%, 100g

t-butyl nitrite, 87.0%, 10g

tert-Butyl 2,6-diazaspiro[3.5]nonane-2-carboxylate hemioxalate, 97%, 5g

Recipiente di reazione a flangia piatta cilindrico, graduato (2) Fondo piatto, DN 150, 160 mm, Altezza, 250 mm, 1 Pezzo

Ethyl 6-bromoimidazo[1,2-a]pyrazine-3-carboxylate, 97.0%, 1g

2-methyl-5,6-dihydro-1,4-oxathiine-3-carboxylic acid, 95.0%, 100mg

1,3,2-DIOXABOROLANE, 2-(3-CHLORO-4-PHENOXYPHENYL)-4,4,5,5-TETRAMETHYL-, 95.0%, 1g

(2s)-2-Benzenesulfonamidopropanoic acid, 95%, 1g

2,3-Pyridinedicarboxylic Anhydride>95.0%(T)5g